These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38689115)

  • 1. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery.
    Chen X; Parekh VS; Peng L; Chan MD; Redmond KJ; Soike M; McTyre E; Lin D; Jacobs MA; Kleinberg LR
    Neurooncol Adv; 2021; 3(1):vdab150. PubMed ID: 34901857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.
    Mouraviev A; Detsky J; Sahgal A; Ruschin M; Lee YK; Karam I; Heyn C; Stanisz GJ; Martel AL
    Neuro Oncol; 2020 Jun; 22(6):797-805. PubMed ID: 31956919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of machine learning methods in delta-radiomics feature analysis.
    Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
    PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation.
    Park YW; Choi D; Park JE; Ahn SS; Kim H; Chang JH; Kim SH; Kim HS; Lee SK
    Sci Rep; 2021 Feb; 11(1):2913. PubMed ID: 33536499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
    Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical model-based parameters to classify tumor recurrence from radiation-induced necrosis for brain metastases.
    Narasimhan S; Johnson HB; Nickles TM; Miga MI; Rana N; Attia A; Weis JA
    Med Phys; 2019 May; 46(5):2487-2496. PubMed ID: 30816555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Recurrence from Radiation Necrosis in Gliomas Based on the Radiomics of Combinational Features and Multimodality MRI Images.
    Zhang Q; Cao J; Zhang J; Bu J; Yu Y; Tan Y; Feng Q; Huang M
    Comput Math Methods Med; 2019; 2019():2893043. PubMed ID: 31871484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
    Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
    Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
    Menoux I; Noël G; Namer I; Antoni D
    Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
    Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
    J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
    Narloch JL; Farber SH; Sammons S; McSherry F; Herndon JE; Hoang JK; Yin FF; Sampson JH; Fecci PE; Blackwell KL; Kirkpatrick JP; Kim GJ
    Neuro Oncol; 2017 Oct; 19(10):1391-1397. PubMed ID: 28472527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.